Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,517 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06583525Enrolling by invitation
Testing the TAC Program for teens with complex health needs
This study tests a program called TAC that helps teens with complex health needs move from SickKids to adult health care. It's for 16- to 18-year-olds who have multiple long-term conditions or a rare disease and might need extra support during this big change.
Toronto, OntarioAges 16–18 - NCT06581120Enrolling by invitation
Stomach ultrasound study for diabetes and obesity
This study uses ultrasound to see how GLP-1 RA medications (like Ozempic) affect the stomach in people with type 2 diabetes and obesity. It may help doctors better understand how these medicines work.
Cincinnati, OhioAges 10–25 - NCT06573671Enrolling by invitation
Histiocytosis in people who inject drugs
This trial looks at a condition called PVP-histiocytosis, which can happen in people who inject drugs made from tablets containing polyvinylpyrrolidone (PVP). The goal is to study these cases to better understand the condition.
Tampere, PirkanmaaAges 18–70 - NCT06571877Enrolling by invitation
Bed rest study: how energy density affects eating
This study looks at how the amount of energy in food affects how much people eat when they are on bed rest. Healthy volunteers will stay in bed for a period of time, and researchers will measure their food intake to understand the relationship between energy density and appetite.
Tübingen, Baden-WurttembergAges 18–99 - NCT06570109Enrolling by invitation
Risk and outcomes of frailty in Alzheimer's dementia
This study looks at how frailty affects people newly diagnosed with Alzheimer's dementia. It aims to understand risk factors and outcomes to help improve care.
AalborgAges 65 years+ - NCT06558201Enrolling by invitation
Open-label extension for completers of earlier study
This trial is for people who finished a 12-week study (NCT06221852) and still meet its original requirements. It offers continued access to the study treatment.
Belmont, MassachusettsAges 18–45 - NCT06557928Enrolling by invitation
Study of body and mind changes in the Tibetan plateau
This study looks at how healthy people's bodies and minds adapt when they travel to the high-altitude Tibetan plateau. It aims to help understand the changes and find ways to support people working there.
BeijingAges 18–50 - NCT06551727Enrolling by invitation
Stroke progression treatment: blood pressure and antiplatelet therapy
This trial tests a combination of blood pressure control and antiplatelet therapy for people whose stroke symptoms are getting worse. It is looking for those without a large brain artery clot or heart-related cause.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06547762Enrolling by invitation
Hybrid rehab for kids with physical disabilities
This trial tests a hybrid approach to rehabilitation for children with physical disabilities, combining in-person and technology-based care. If your child gets outpatient therapy more than once a week and can follow instructions with your help using a computer, this might be a good fit.
JerusalemAges 3–21 - NCT06545305Enrolling by invitation
Eye problems in homocystinuria patients, 2018–2022
This study looks at eye problems in people with homocystinuria. It will review medical records from 2018 to 2022 to find out how common eye issues are and what might increase the risk.
JeddahAges 20–30 - NCT06544109Enrolling by invitationPhase 2/Phase 3
Venetoclax to prevent differentiation syndrome in APL
This trial tests adding venetoclax to standard treatment to prevent a serious side effect called differentiation syndrome in people with newly diagnosed acute promyelocytic leukemia (APL). Patients must be healthy enough to receive intensive chemotherapy.
Suzhou, JiangsuAges Any age - NCT06542575Enrolling by invitation
Home heart rehab with app after stent
This trial tests a home-based program that uses a smartphone app (digital therapy) to help people with high-risk heart conditions after a stent procedure. The goal is to improve recovery through exercise and lifestyle support, all from home.
Chengdu, SichuanAges 18–75 - NCT06540508Enrolling by invitation
TACE with targeted immunotherapy for advanced liver cancer
This study looks at whether combining a liver-directed procedure called TACE with tiragolumab and targeted therapy works better for people with unresectable liver cancer that has not spread too far. Researchers will use blood and tissue tests to see how well the treatment works.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06540027Enrolling by invitation
Minimally invasive surgery for rectal cancer inflammation
This study looks at how different types of surgery (open, laparoscopic, or robotic) affect inflammation throughout the body in people with rectal cancer. It may help doctors understand which approach is gentler on your immune system.
IstanbulAges Any age - NCT06534281Enrolling by invitationEarly Phase 1
BAO-G technique for TAAA aneurysm repair
This trial is testing a new technique (BAO-G) for repairing a thoracoabdominal aortic aneurysm (TAAA) using a stent placed through a blood vessel in the leg. It is for people with a large aneurysm or one causing symptoms, who have not had prior aortic repair.
BeijingAges 18–80 - NCT06533007Enrolling by invitation
How PDE3B affects metabolism in healthy adults
This study looks at how a protein called PDE3B affects your body's metabolism (how it uses energy). It may help researchers understand weight and insulin resistance better, which could lead to new treatments.
CambridgeAges 21–75 - NCT06529042Enrolling by invitation
Sickle Cell Risk in Pregnancy Tool Study
This study is developing a risk assessment tool to help predict complications in pregnant women with sickle cell disease. It reviews medical records from women who have received prenatal care and given birth at participating hospitals.
Baltimore, MarylandAges 16–60 - NCT06522321Enrolling by invitationPhase 2
Bone graft with platelet gel for immediate dental implants
This trial tests whether adding a special platelet-rich fibrin (I-PRF) to a standard bone graft (FDBA) helps preserve bone around dental implants placed right after a tooth is pulled. If you have a damaged single-rooted tooth and are in good health, you may be able to join.
Bengaluru, KarnatakaAges 18–55 - NCT06519448Enrolling by invitation
Testing a pill for non-alcoholic fatty liver disease
This trial tests a diabetes drug called empagliflozin to see if it can reduce fat and inflammation in the liver in people with a specific type of fatty liver disease called NASH. It may help if you have NASH and either have type 2 diabetes or don't have it.
PragueAges 18–75 - NCT06518668Enrolling by invitationPhase 1
NKX019 cell therapy for lupus
This study tests a new therapy called NKX019, which uses specially engineered natural killer cells to target a protein on lupus cells. It is for people with moderate to severe lupus that has not responded to standard treatments, especially those with active kidney inflammation.
New York, New YorkAges 18–65 - NCT06510634Enrolling by invitation
Stroke treatment after 24 hours for vertebrobasilar blockage
This trial tests a method to triage people who had a stroke in the back part of the brain (vertebrobasilar artery) more than 24 hours ago. The goal is to find the best way to decide which patients may still benefit from treatment.
Tianjin, Tianjin MunicipalityAges 18–90 - NCT06510127Enrolling by invitation
AI Predicts Chemo Effectiveness Before Breast Surgery
This study uses an AI model to predict how well chemotherapy will work before breast cancer surgery. It looks back at medical records and images from women who have already completed treatment to see if the AI can help guide future care.
Guangzhou, GuangdongAges Any age - NCT06509022Enrolling by invitation
Reflux study after esophageal cancer surgery
This study is for people who have had surgery for esophageal cancer. It uses a special test called PEPTEST to track acid reflux after surgery and find out what affects it.
BeijingAges Any age - NCT06503939Enrolling by invitation
Treating long COVID cough with inhaled steroids
This trial is testing if inhaled steroid medications (ICS or ICS/LABA) can help people whose cough continues long after a COVID-19 infection. It is designed for adults whose cough started after a positive COVID test and has lasted more than 8 weeks without other lung issues.
Changsha, HunanAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,517 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.